Is oral anticoagulation plus antiplatelet therapy superior to oral anticoagulation alone in patients with atrial fibrillation and stable coronary artery disease?

J Interv Card Electrophysiol. 2023 Aug;66(5):1031-1032. doi: 10.1007/s10840-022-01379-7. Epub 2022 Oct 15.

Authors

Virginia Laura Gonzalez¹, Mario Daniel Gonzalez²

Affiliations

¹ Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
² Division of Electrophysiology, Heart and Vascular Institute, Penn State Health Milton S. Hershey Medical Center, Penn State University School of Medicine, Hershey, PA, USA. mgonzalez@pennstatehealth.psu.edu.

PMID: 36242677
DOI: 10.1007/s10840-022-01379-7

No abstract available

Publication types

Editorial

MeSH terms

Administration, Oral
Anticoagulants / therapeutic use
Atrial Fibrillation* / drug therapy
Blood Coagulation
Coronary Artery Disease* / drug therapy
Drug Therapy, Combination
Humans
Percutaneous Coronary Intervention*
Platelet Aggregation Inhibitors / therapeutic use
Stroke*

Substances

Platelet Aggregation Inhibitors
Anticoagulants